Amneal Pharmaceuticals (AMRX) Dividends Paid - Common (2017 - 2018)
Amneal Pharmaceuticals' (AMRX) quarterly Dividends Paid - Common came in at $153.0 million in Q2 2018, up 409.99% quarter-over-quarter from $30.0 million in Q1 2018.
Amneal Pharmaceuticals (AMRX) Dividends Paid - Common (2017 - 2018) Analysis & Trends
Amneal Pharmaceuticals' Dividends Paid - Common history runs 2 years deep, the most recent figure standing at $153.0 million for Q2 2018.
- On a quarterly basis, Dividends Paid - Common changed N/A year-over-year to $153.0 million in Q2 2018; TTM through Mar 2019 was $153.0 million, a N/A change from a year earlier, with the FY2018 full-year figure at $183.0 million, down 51.23% from the prior year.
- Dividends Paid - Common grew to $153.0 million in Q2 2018 per AMRX's latest filing, from $30.0 million in the prior quarter.
- Across five years, Dividends Paid - Common topped out at $153.0 million in Q2 2018 and bottomed at $20.0 million in Q4 2017.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Dividends Paid - Common (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | - |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 224.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 3.92 Bn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | - |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 139.60 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | - |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | - |
| 10 | Amneal Pharmaceuticals | 5.68 Bn | 5.67 Bn | 320.11 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2018 | 153.00 Mn |
| Jun 30, 2018 | 153.00 Mn |
| Mar 31, 2018 | 30.00 Mn |
| Mar 31, 2018 | 30.00 Mn |
| Dec 31, 2017 | 20.00 Mn |
| Dec 31, 2017 | 20.00 Mn |
| Sep 30, 2017 | 60.00 Mn |
| Sep 30, 2017 | 60.00 Mn |